IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...
Scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research Foundation (MMRF ...
Fortunately, eight days after surgery, I received the pathology report and was elated to read that it was an oncocytoma ...
aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...
Sportschosun on MSN
Ilsan Paik Hospital, Rh-type, 20cm giant uterine myoma patient succeeded in hysterectomy robot surge...
Jeon Kyung-chul, a professor of obstetrics and gynecology at Ilsan Paik Hospital in Inje University, successfully performed a ...
Morning Overview on MSN
New imaging breakthrough makes cancer cells light up on cue
Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical precision. Across operating rooms, scanners, and even blood tests, ...
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2025 /PRNewswire/ -- Link Cell Therapies ("Link"), an oncology cell therapy company, today announced its official launch from stealth with a $60 million Series A ...
Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that go after a range of tumors while avoiding patients' healthy tissue. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback